Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Role of viral and host factors in interferon based therapy of hepatitis C virus infection.

Imran M, Manzoor S, Ashraf J, Khalid M, Tariq M, Khaliq HM, Azam S.

Virol J. 2013 Oct 1;10:299. doi: 10.1186/1743-422X-10-299. Review.

PMID:
24079723
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.

Murata K, Sugiyama M, Kimura T, Yoshio S, Kanto T, Kirikae I, Saito H, Aoki Y, Hiramine S, Matsui T, Ito K, Korenaga M, Imamura M, Masaki N, Mizokami M.

J Gastroenterol. 2014 Jan;49(1):126-37. doi: 10.1007/s00535-013-0814-1. Epub 2013 Apr 17.

PMID:
23591768
[PubMed - in process]
Free PMC Article
3.

MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells.

Shirasaki T, Honda M, Shimakami T, Horii R, Yamashita T, Sakai Y, Sakai A, Okada H, Watanabe R, Murakami S, Yi M, Lemon SM, Kaneko S.

J Virol. 2013 May;87(9):5270-86. doi: 10.1128/JVI.03022-12. Epub 2013 Feb 28.

PMID:
23449803
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.

Berger CT, Kim AY.

Infect Dis Clin North Am. 2012 Dec;26(4):863-77. doi: 10.1016/j.idc.2012.08.010. Review.

PMID:
23083820
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.

Anthony DD, Conry SJ, Medvik K, Sandhya Rani MR, Falck-Ytter Y, Blanton RE, Lederman MM, Rodriguez B, Landay AL, Sandberg JK.

J Infect Dis. 2012 Sep 15;206(6):969-73. doi: 10.1093/infdis/jis434. Epub 2012 Jul 10.

PMID:
22782948
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.

Myers RP, Ramji A, Bilodeau M, Wong S, Feld JJ.

Can J Gastroenterol. 2012 Jun;26(6):359-75.

PMID:
22720279
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.

Uto H, Mawatari S, Kumagai K, Ido A, Tsubouchi H.

Hepat Mon. 2012 Feb;12(2):77-84. doi: 10.5812/hepatmon.829. Epub 2012 Feb 29.

PMID:
22509183
[PubMed]
Free PMC Article
8.

Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.

Conry SJ, Meng Q, Hardy G, Yonkers NL, Sugalski JM, Hirsch A, Davitkov P, Compan A, Falck-Ytter Y, Blanton RE, Rodriguez B, Harding CV, Anthony DD.

J Infect Dis. 2012 Apr 1;205(7):1131-41. doi: 10.1093/infdis/jis027. Epub 2012 Feb 20.

PMID:
22351942
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Hildesheim A, Wang CP.

Semin Cancer Biol. 2012 Apr;22(2):107-16. doi: 10.1016/j.semcancer.2012.01.007. Epub 2012 Jan 25. Review.

PMID:
22300735
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Adjuvant therapy: melanoma.

Davar D, Tarhini A, Kirkwood JM.

J Skin Cancer. 2011;2011:274382. doi: 10.1155/2011/274382. Epub 2011 Dec 19.

PMID:
22220281
[PubMed]
Free PMC Article
11.

Evolutionary genetic dissection of human interferons.

Manry J, Laval G, Patin E, Fornarino S, Itan Y, Fumagalli M, Sironi M, Tichit M, Bouchier C, Casanova JL, Barreiro LB, Quintana-Murci L.

J Exp Med. 2011 Dec 19;208(13):2747-59. doi: 10.1084/jem.20111680. Epub 2011 Dec 12.

PMID:
22162829
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort.

Smith KR, Suppiah V, O'Connor K, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Matthews G, Irving WL, Powell E, Riordan S, Ahlenstiel G, Stewart GJ, Bahlo M, George J, Booth DR; International Hepatitis C Genetics Consortium (IHCGC).

Genome Med. 2011 Aug 31;3(8):57. doi: 10.1186/gm273.

PMID:
21884576
[PubMed]
Free PMC Article
13.

An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.

O'Brien TR, Everhart JE, Morgan TR, Lok AS, Chung RT, Shao Y, Shiffman ML, Dotrang M, Sninsky JJ, Bonkovsky HL, Pfeiffer RM; HALT-C Trial Group.

PLoS One. 2011;6(7):e20904. doi: 10.1371/journal.pone.0020904. Epub 2011 Jul 8.

PMID:
21760886
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

HBV life cycle and novel drug targets.

Grimm D, Thimme R, Blum HE.

Hepatol Int. 2011 Jun;5(2):644-53. doi: 10.1007/s12072-011-9261-3. Epub 2011 Mar 8.

PMID:
21484123
[PubMed]
Free PMC Article
15.

Genomics and drug response.

Wang L, McLeod HL, Weinshilboum RM.

N Engl J Med. 2011 Mar 24;364(12):1144-53. doi: 10.1056/NEJMra1010600. Review. No abstract available.

PMID:
21428770
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.

Freedman ND, Curto TM, Lindsay KL, Wright EC, Sinha R, Everhart JE; HALT-C TRIAL GROUP.

Gastroenterology. 2011 Jun;140(7):1961-9. doi: 10.1053/j.gastro.2011.02.061. Epub 2011 Mar 2.

PMID:
21376050
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.

Hsu CS, Hsu SJ, Chen HC, Tseng TC, Liu CH, Niu WF, Jeng J, Liu CJ, Lai MY, Chen PJ, Kao JH, Chen DS.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3719-24. doi: 10.1073/pnas.1100349108. Epub 2011 Feb 14.

PMID:
21321200
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

IL28B-genotype testing now and in the era of direct-acting antiviral agents.

Morgan TR, O'Brien TR.

Clin Gastroenterol Hepatol. 2011 Apr;9(4):293-4. doi: 10.1016/j.cgh.2010.12.014. Epub 2010 Dec 23. No abstract available.

PMID:
21185399
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.

Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L.

J Virol. 2010 Jul;84(14):6987-94. doi: 10.1128/JVI.00196-10. Epub 2010 May 12.

PMID:
20463075
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk